Germany is resisting momentum to lift patent protection for Covid-19 vaccines, saying Thursday that a US decision to support such waivers “has significant implications for vaccine production.”
Germany is resisting momentum to lift patent protection for Covid-19 vaccines, saying Thursday that a US decision to support such waivers “has significant implications for vaccine production.”